HOME >> BIOLOGY >> NEWS
Vioxx in high doses causes hypertension

at if 25 milligrams works well, then 50 milligrams is going to work better," Griffin said. "But when you look at the scant data that's out there for chronic pain, there's been no study that shows that 50 is better than 25.

"This is really common with a lot of drugs, that there's a ceiling on the effective dose But unfortunately, there's usually not a ceiling on the side effects."

Griffin and her colleagues, who include Wayne A. Ray, Ph.D., professor of Preventive Medicine, and C. Michael Stein, M.D., professor of Medicine, have been sounding the alarm about high-dose Vioxx use since 2002.

In a study of TennCare participants published in the journal Lancet that year, the researchers reported patients on high doses of Vioxx had nearly twice the rate of serious heart problems, including heart attacks and heart-related deaths, compared to patients not on the drug.

Other groups have reported similar findings among high-dose Vioxx users: an increased risk of heart attack and congestive heart failure, a rise in blood pressure and a greater incidence of edema, or swelling, in the arms and legs, which can put extra strain on the heart. Griffin said that high doses of Vioxx might be particularly hard on the kidney, resulting in fluid retention, edema and a rise in blood pressure.

Some doctors won't prescribe Vioxx for patients at risk for developing high blood pressure, because the drug could make that condition more difficult to control, Griffin said. However, many other doctors apparently underestimate the drug's ability to cause edema, hypertension and heart failure, she added.

Of the TennCare patients in the Vanderbilt study who were receiving over 25 milligrams of Vioxx a day, 15 percent had been treated for congestive heart failure during the previous 12 months, and 22 percent had been treated for other forms of heart disease, the researchers reported.

"Educating all clinicians about this is a very difficult task
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
13-Jul-2004


Page: 1 2 3

Related biology news :

1. PTEN and prostate cancer--the devil is in the doses
2. Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream
3. UT Southwestern researchers say overdoses of acetaminophen cause most cases of acute liver failure
4. Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers
5. Low doses of radiation in nature may pose more risk
6. Gel may cut doses for some medications
7. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
8. Pollutant causes delayed flowering in plants
9. Disruption of protein-folding causes neurodegeneration, mental retardation
10. Researchers discover why mutant gene causes colon cancer
11. Analysis fingers causes of desertification

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... LUXEMBOURG (PRWEB) , ... August ... ... Luxembourg-based clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with ... of enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
Cached News: